Home

kő előnyös Jelentőség overall response rate holdall Refrén Shipley

Overall Response Rate of 76% in Advanced Melanoma Patients with Dynavax's  SD-101 in Combination with KEYTRUDA® (pembrolizumab); Data Presented Today  at the 2019 ASCO Annual Meeting | Dynavax Technologies Corporation
Overall Response Rate of 76% in Advanced Melanoma Patients with Dynavax's SD-101 in Combination with KEYTRUDA® (pembrolizumab); Data Presented Today at the 2019 ASCO Annual Meeting | Dynavax Technologies Corporation

Cell therapy doubles survival, response rates in advanced melanoma
Cell therapy doubles survival, response rates in advanced melanoma

Forest plot of the comparison of overall response rate (ORR).
Forest plot of the comparison of overall response rate (ORR).

Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and  Children | NEJM
Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children | NEJM

Response rates Overall response rate and depth of response according to...  | Download Scientific Diagram
Response rates Overall response rate and depth of response according to... | Download Scientific Diagram

Nexcella Announces Positive 58-Patient NXC- 201 Clinical Data: 100% Overall  Response Rate in light chain (AL) Amyloidosis; 92% Overall Response Rate in  Multiple Myeloma at the EBMT 49th Annual Meeting in Paris | BioSpace
Nexcella Announces Positive 58-Patient NXC- 201 Clinical Data: 100% Overall Response Rate in light chain (AL) Amyloidosis; 92% Overall Response Rate in Multiple Myeloma at the EBMT 49th Annual Meeting in Paris | BioSpace

Durable Response Rate
Durable Response Rate

ODOMZO® (sonidegib) | Efficacy Data
ODOMZO® (sonidegib) | Efficacy Data

Overall response rate | Download Table
Overall response rate | Download Table

Efficacy | Tivdak® (tisotumab vedotin-tftv)
Efficacy | Tivdak® (tisotumab vedotin-tftv)

Objective response rate of placebo in randomized controlled trials of  anticancer medicines - eClinicalMedicine
Objective response rate of placebo in randomized controlled trials of anticancer medicines - eClinicalMedicine

RESONATE-2 - Overall Response Rate | IMBRUVICA® (ibrutinib) HCP
RESONATE-2 - Overall Response Rate | IMBRUVICA® (ibrutinib) HCP

Efficacy - Overall Response Rate | Aliqopa US HCP
Efficacy - Overall Response Rate | Aliqopa US HCP

Comparing Outcomes in Patients with Recurrent or Refractory Ovarian Cancer  Managed with 1 of 2 Versions of Pegylated Liposomal Doxorubicin at an  Academic Medical Center
Comparing Outcomes in Patients with Recurrent or Refractory Ovarian Cancer Managed with 1 of 2 Versions of Pegylated Liposomal Doxorubicin at an Academic Medical Center

Efficacy endpoints in Oncology
Efficacy endpoints in Oncology

What Low Response Rates Mean for Telephone Surveys | Pew Research Center
What Low Response Rates Mean for Telephone Surveys | Pew Research Center

Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know

Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know

COTELLIC® (cobimetinib) + ZELBORAF® (vemurafenib) Objective Response Rate
COTELLIC® (cobimetinib) + ZELBORAF® (vemurafenib) Objective Response Rate

Blood-based tumor mutational burden as a biomarker for atezolizumab in  non-small cell lung cancer: the phase 2 B-F1RST trial | Nature Medicine
Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial | Nature Medicine

Updated Data for Indoximod Plus KEYTRUDA® (pembrolizumab) Demonstrate  Improvement of Response Rate for Patients with Advanced Melanoma | Business  Wire
Updated Data for Indoximod Plus KEYTRUDA® (pembrolizumab) Demonstrate Improvement of Response Rate for Patients with Advanced Melanoma | Business Wire

Zacks Small Cap Research - ONCS: New Data Provide Evidence that ImmunoPulse  IL-12 Can Prime the Immune System
Zacks Small Cap Research - ONCS: New Data Provide Evidence that ImmunoPulse IL-12 Can Prime the Immune System